185 related articles for article (PubMed ID: 29560375)
1. Targeting potassium channels to treat cerebellar ataxia.
Bushart DD; Chopra R; Singh V; Murphy GG; Wulff H; Shakkottai VG
Ann Clin Transl Neurol; 2018 Mar; 5(3):297-314. PubMed ID: 29560375
[TBL] [Abstract][Full Text] [Related]
2. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG
J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia.
Srinivasan SR; Huang H; Chang WC; Nasburg JA; Nguyen HM; Strassmaier T; Wulff H; Shakkottai VG
Mol Pharmacol; 2022 Jul; 102(1):438-449. PubMed ID: 35489717
[TBL] [Abstract][Full Text] [Related]
4. Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1.
Chopra R; Bushart DD; Shakkottai VG
PLoS One; 2018; 13(5):e0198040. PubMed ID: 29847609
[TBL] [Abstract][Full Text] [Related]
5. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
Shuvaev AN; Hosoi N; Sato Y; Yanagihara D; Hirai H
J Physiol; 2017 Jan; 595(1):141-164. PubMed ID: 27440721
[TBL] [Abstract][Full Text] [Related]
6. A Chlorzoxazone-Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1.
Bushart DD; Huang H; Man LJ; Morrison LM; Shakkottai VG
Mov Disord; 2021 Mar; 36(3):622-631. PubMed ID: 33151010
[TBL] [Abstract][Full Text] [Related]
7. Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2.
Dell'Orco JM; Pulst SM; Shakkottai VG
Hum Mol Genet; 2017 Oct; 26(20):3935-3945. PubMed ID: 29016852
[TBL] [Abstract][Full Text] [Related]
8. Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3.
Bushart DD; Zalon AJ; Zhang H; Morrison LM; Guan Y; Paulson HL; Shakkottai VG; McLoughlin HS
Cerebellum; 2021 Feb; 20(1):41-53. PubMed ID: 32789747
[TBL] [Abstract][Full Text] [Related]
9. Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Hourez R; Servais L; Orduz D; Gall D; Millard I; de Kerchove d'Exaerde A; Cheron G; Orr HT; Pandolfo M; Schiffmann SN
J Neurosci; 2011 Aug; 31(33):11795-807. PubMed ID: 21849540
[TBL] [Abstract][Full Text] [Related]
10. [Exploration of preventive drugs for spinocerebellar ataxia using cultured cerebellar Purkinje cells].
Seki T
Nihon Yakurigaku Zasshi; 2019; 154(6):310-314. PubMed ID: 31787682
[TBL] [Abstract][Full Text] [Related]
11. Increased intrinsic membrane excitability is associated with hypertrophic olivary degeneration in spinocerebellar ataxia type 1.
Morrison LM; Huang H; Handler HP; Fu M; Bushart DD; Pappas SS; Orr HT; Shakkottai VG
bioRxiv; 2023 Oct; ():. PubMed ID: 37961407
[TBL] [Abstract][Full Text] [Related]
12. Translating cerebellar Purkinje neuron physiology to progress in dominantly inherited ataxia.
Chopra R; Shakkottai VG
Future Neurol; 2014 Mar; 9(2):187-196. PubMed ID: 25221437
[TBL] [Abstract][Full Text] [Related]
13. Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14.
Ji J; Hassler ML; Shimobayashi E; Paka N; Streit R; Kapfhammer JP
Neurobiol Dis; 2014 Oct; 70():1-11. PubMed ID: 24937631
[TBL] [Abstract][Full Text] [Related]
14. Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
Shimobayashi E; Kapfhammer JP
Curr Neuropharmacol; 2018 Jan; 16(2):151-159. PubMed ID: 28554312
[TBL] [Abstract][Full Text] [Related]
15. Ion channel dysfunction in cerebellar ataxia.
Bushart DD; Shakkottai VG
Neurosci Lett; 2019 Jan; 688():41-48. PubMed ID: 29421541
[TBL] [Abstract][Full Text] [Related]
16. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
17. An active membrane model of the cerebellar Purkinje cell. I. Simulation of current clamps in slice.
De Schutter E; Bower JM
J Neurophysiol; 1994 Jan; 71(1):375-400. PubMed ID: 7512629
[TBL] [Abstract][Full Text] [Related]
18. Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia.
Huang H; Shakkottai VG
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374132
[TBL] [Abstract][Full Text] [Related]
19. In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.
Egorova PA; Zakharova OA; Vlasova OL; Bezprozvanny IB
J Neurophysiol; 2016 Jun; 115(6):2840-51. PubMed ID: 26984424
[TBL] [Abstract][Full Text] [Related]
20. Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model.
Ferro A; Carbone E; Zhang J; Marzouk E; Villegas M; Siegel A; Nguyen D; Possidente T; Hartman J; Polley K; Ingram MA; Berry G; Reynolds TH; Possidente B; Frederick K; Ives S; Lagalwar S
PLoS One; 2017; 12(12):e0188425. PubMed ID: 29211771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
